New Opioids Guidance!
APHL Model Opioids Biosurveillance
Strategy for Public Health Practice
July 2020
The APHL Opioids Biosurveillance Task Force has
outlined guidance for public health laboratories at
various stages of designing, implementing, and
evaluating opioids biosurveillance programs. Applying
the strategy can help your laboratory strengthen its
role in addressing the opioid epidemic.
• Topics covered include laboratory testing, data
sharing, and stakeholder collaboration.
• Laboratories are strongly encouraged to share
and discuss this guidance closely with clinicians,
epidemiologists, and others involved in opioids
biosurveillance in their jurisdictions
Find this tool and more at www.aphl.org/opioids
For questions and additional information, contact:
Nicholas Ancona, MPH
Specialist, Opioids Biosurveillance
[email protected]
240.485.3849
Also Now Available: Application
Guide for New DEA Registrants
PublicHealthLabs
@APHL
APHL.org
Summer 2020 LAB MATTERS 19